To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: CRISPR Therapeutics, Momenta

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) promoted Samarth Kulkarni to CEO from president of the company's U.S. subsidiary CRISPR Therapeutics Inc.,

Read the full 222 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE